找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: 30th Hemophilia Symposium Hamburg 1999; HIV Infection and Ep Inge Scharrer,Wolfgang Schramm Conference proceedings 2001 Springer Verlag Ber

[复制链接]
楼主: 强烈兴趣
发表于 2025-3-26 21:46:12 | 显示全部楼层
发表于 2025-3-27 02:51:23 | 显示全部楼层
发表于 2025-3-27 09:03:10 | 显示全部楼层
Functional Consequences of Differences in Carbohydrate Sequences of Fetal and Adult Plasminogen and ge stakeholders’ needs — technical, financial, legal, and environmental aspects, customer requirements, Corporate strategy, etc. -, being a multidisciplinary and strategic issue. An approach to use real option to support the decision-making process at PDP phases in taken. The real option valuation m
发表于 2025-3-27 10:07:56 | 显示全部楼层
Hereditary Thrombophilic Risk Profiles in Children with Spontaneous Venous Thromboembolismms design is reused and customized to meet diverse customer requirements such as application, cost, and operational considerations. Many of these dynamic changes in nature have required system design component variations referred to as “variants” on top of a fixed master design. One approach to real
发表于 2025-3-27 17:30:16 | 显示全部楼层
Inhibitor Development in Previously Untreated Patients with Hemophilia A and B: A Prospective 23-Yean & Management" (CSDM 2014) international conference held in. This book contains all refereed papers that were accepted to the fifth edition of the « Complex Systems Design & Management » (CSD&M 2014) international conference which took place in Paris (France) on the November 12-14, 2014..These proc
发表于 2025-3-27 21:25:49 | 显示全部楼层
dern treatment of hemophilia, drug-induced thrombophilia and pediatric hemostasiology. The volume is rounded off by numerous free papers and posters on hemophilia and associated topics.978-3-540-67677-5978-3-642-18240-2
发表于 2025-3-27 23:44:25 | 显示全部楼层
发表于 2025-3-28 04:51:01 | 显示全部楼层
发表于 2025-3-28 09:49:31 | 显示全部楼层
How to Set Things Up? Study Designs,III; substitution by exogenous factor VIII concentrates is the main form of medical treatment. In Germany, about 5800 patients are affected; the average cost for the treatment is about 100,000 DM per patient per year, totaling more than 500 million DM per year. Worldwide, only 20% of patients can be treated because of the expense of the therapy.
发表于 2025-3-28 11:15:15 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-5 00:02
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表